이 에피소드에 관해
In this episode, I explore how long-acting injectable medications, like Vivitrol, Sublocade, and Brixadi, are reshaping treatment for opioid use disorder by reducing daily dosing burdens and improving treatment adherence. I review evidence on their clinical effectiveness, patient experiences, and the practical and ethical considerations involved in implementing these medications in both community and carceral settings.
This project was supported by Grant [5PBJA-22-AG-00031-MUMU] awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Points of view or opinions in this podcast are those of the host and the research team and do not necessarily represent the official position or policies of the U.S. Department of Justice.
